155 related articles for article (PubMed ID: 1350507)
21. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines.
Zaman GJ; Versantvoort CH; Smit JJ; Eijdems EW; de Haas M; Smith AJ; Broxterman HJ; Mulder NH; de Vries EG; Baas F
Cancer Res; 1993 Apr; 53(8):1747-50. PubMed ID: 8467491
[TBL] [Abstract][Full Text] [Related]
22. Intracellular expression of P-glycoprotein in a human colon tumor cell line.
Duensing TD; Slate DL
Anticancer Res; 1994; 14(1A):13-9. PubMed ID: 7513140
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
24. Genes amplified and overexpressed in human multidrug-resistant cell lines.
Van der Bliek AM; Baas F; Van der Velde-Koerts T; Biedler JL; Meyers MB; Ozols RF; Hamilton TC; Joenje H; Borst P
Cancer Res; 1988 Nov; 48(21):5927-32. PubMed ID: 2901906
[TBL] [Abstract][Full Text] [Related]
25. Expression of multidrug resistance gene (MDR-1) in human normal leukocytes.
Damiani D; Michieli M; Michelutti A; Geromin A; Raspadori D; Fanin R; Savignano C; Giacca M; Pileri S; Mallardi F
Haematologica; 1993; 78(1):12-7. PubMed ID: 8098310
[TBL] [Abstract][Full Text] [Related]
26. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
27. Lack of expression of P-glycoprotein in 7 small cell lung cancer cell lines established both from untreated and from treated patients.
Milroy R; Plumb JA; Batstone P; Maclay A; Wishart GC; Hay FG; Candlish W; Adamson R; Khan MZ; Banham S
Anticancer Res; 1992; 12(1):193-200. PubMed ID: 1348921
[TBL] [Abstract][Full Text] [Related]
28. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
Kong D; Yamori T
Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
[TBL] [Abstract][Full Text] [Related]
29. [Detection of multidrug resistant phenotype in leukemia and lymphoma by monoclonal antibodies].
Shimoyama M; Ohtsu T; Ishida Y; Kuroki Y; Shimada Y; Tobinai K; Minato K; Hamada H; Tsuruo T
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2863-70. PubMed ID: 2902832
[TBL] [Abstract][Full Text] [Related]
30. Is the mdr 1 gene relevant in chronic lymphocytic leukemia?
Holmes JA; Jacobs A; Carter G; Whittaker JA; Bentley DP; Padua RA
Leukemia; 1990 Mar; 4(3):216-8. PubMed ID: 1690320
[TBL] [Abstract][Full Text] [Related]
31. Genetic aspects of multidrug resistance.
Biedler JL
Cancer; 1992 Sep; 70(6 Suppl):1799-809. PubMed ID: 1355404
[TBL] [Abstract][Full Text] [Related]
32. Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment.
Gullbo J; Fryknäs M; Rickardson L; Darcy P; Hägg M; Wickström M; Hassan S; Westman G; Brnjic S; Nygren P; Linder S; Larsson R
Biochem Pharmacol; 2011 Jul; 82(2):139-47. PubMed ID: 21531212
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
Noonan KE; Beck C; Holzmayer TA; Chin JE; Wunder JS; Andrulis IL; Gazdar AF; Willman CL; Griffith B; Von Hoff DD; Roninson IB
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7160-4. PubMed ID: 1976252
[TBL] [Abstract][Full Text] [Related]
34. [A molecular basis for multidrug-resistance and reversal of resistance with human malignant cells].
Akiyama S; Kikuchi H; Yoshimura A; Matsumoto M
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2617-25. PubMed ID: 2888434
[TBL] [Abstract][Full Text] [Related]
35. Increased mdr gene expression and decreased drug accumulation in a human colonic cancer cell line resistant to hydrophobic drug.
Chao CC; Ma CM; Cheng PW; Lin-Chao S
Biochem Biophys Res Commun; 1990 Oct; 172(2):842-9. PubMed ID: 2122897
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric analysis of multidrug-resistance-associated antigen (P-glycoprotein) and DNA ploidy in human colon cancer.
Danova M; Giordano M; Erba E; Palmeri S; Candiloro V; Riccardi A; Ucci G; Mazzini G; D'Incalci M; Ascari E
J Cancer Res Clin Oncol; 1992; 118(8):575-80. PubMed ID: 1355483
[TBL] [Abstract][Full Text] [Related]
37. Studies on low-level MDR cells.
Belvedere G; Dolfini E
Cytotechnology; 1993; 12(1-3):257-64. PubMed ID: 7765328
[TBL] [Abstract][Full Text] [Related]
38. The development and characterization of Vinca alkaloid-resistant Caco-2 human colorectal cell lines expressing mdr-1.
Hoskins J; DeHerdt SV; Moore RE; Bumol TF
Int J Cancer; 1993 Feb; 53(4):680-8. PubMed ID: 8094716
[TBL] [Abstract][Full Text] [Related]
39. Pleiotropic, multidrug-resistant phenotype and P-glycoprotein: a review.
Ban T
Chemotherapy; 1992; 38(3):191-6. PubMed ID: 1355045
[TBL] [Abstract][Full Text] [Related]
40. [Detection of multidrug resistant cells in human malignant diseases by monoclonal antibodies and strategy to eradicate resistant malignant cells].
Shimoyama M; Ohtsu T; Ishida Y; Shimada Y; Tobinai K; Minato K; Tsuruo T
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):611-6. PubMed ID: 2565103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
